---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-203836"
form_type: "8-K"
ticker: "TSHA"
cik: "0001806310"
company_name: "Taysha Gene Therapies, Inc."
filed_at: "2023-08-04T23:59:59+00:00"
generated_at: "2026-06-12T06:14:01.761697+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Taysha Gene Therapies receives Nasdaq notice for non-compliance with MVLS minimum $50M

## Summary
- Received written notice from Nasdaq on Aug 3, 2023 for failing to meet $50M minimum MVLS requirement.
- Has until Jan 30, 2024 to regain compliance by closing at $50M+ for 10 consecutive business days.
- Common stock continues trading on Nasdaq Global Select under TSHA; may consider transfer to Cap Market.
- Company intends to monitor MVLS and explore available options; no immediate delisting.

## SEC filing metadata
- accession: 0001193125-23-203836
- form_type: 8-K
- ticker: TSHA
- cik: 0001806310
- company_name: Taysha Gene Therapies, Inc.
- filed_at: 2023-08-04T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1806310/000119312523203836/0001193125-23-203836-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1806310/000119312523203836/d471821d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-203836
- JSON: https://secwatch.observer/filing/0001193125-23-203836.json
- Plain text: https://secwatch.observer/filing/0001193125-23-203836.txt

## Key facts
- Listing & Compliance Notices
  Taysha Gene Therapies, Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(2)(A)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: market value
  - Rules: 5450(b)(2)(A)
  source text: August 3, 2023, Taysha Gene Therapies, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is no longer in compliance with the minimum Market Value of Listed Securities (“MVLS”) of $50,000,000 required for continued listing on The Nasdaq Global Select Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”). The Notice has no effect at this time on the listing of the Company’s common stock (the “Common Stock”), which continues to trade on The Nasdaq Global Select Market under the symbol “T
  evidence_url: https://www.sec.gov/Archives/edgar/data/1806310/000119312523203836/0001193125-23-203836-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.